November 17, 2023
Parexel named “Best Contract Research Organization” at 19th Annual Scrip Awards
Parexel was named “Best Contract Research Organization” in the Full-Service Provider category at the 19th Annual Scrip Awards. Parexel was selected by a distinguished panel of life science industry executives based on the company’s capabilities and strengths in delivering results to exceed sponsor expectations; innovations in patient engagement and recruitment; commitment to diversity and inclusion in clinical trials and ability to leverage AI and RWE to evolve the clinical development process to better serve patients. The annual Scrip Awards, organized by Citeline, are designed to celebrate and recognize the very best innovations and achievements in global biopharma.
November 8, 2023
Parexel named 2023 HBA ACE Award Honoree
Parexel was recognized with the 2023 Healthcare Businesswomen’s Association’s (HBA) “Advancement. Commitment. Engagement (ACE) Award,” which recognizes companies for their creation and implementation of initiatives that deliver impactful outcomes designed to close the gender gap in the healthcare ecosystem. Parexel was one of two companies chosen as a result of the strong outcomes from its business initiative “Priority: Advancing Women in Leadership.” ACE Award recipients are selected by an independent panel of healthcare industry leaders for their demonstrated efficacy in advancing female talent. Award criteria include measurable results, business performance, stewardship, execution and sustainability.
November 3, 2023
Parexel receives 2023 Triangle Business Journal’s Leaders in Diversity award
Parexel was selected as one of the Triangle Business Journal’s Leaders in Diversity award winners for 2023. Parexel was selected for its notable accomplishments in diversity and inclusion, including its gender initiatives, “Discussions on Diversity” report, diversity committee launches and employee DE&I training. The Leaders in Diversity Awards program, now in its 11th year, is designed to recognize the accomplishments of Triangle area businesses, individuals and nonprofits as they come together to weave a diverse foundational fabric into the heart of the local community.
October 20, 2023
Amy McKee, M.D. named to 2023 PharmaVoice 100
Amy McKee, M.D., Chief Medical Officer and Global Head, Oncology Center of Excellence, was named to the PharmaVoice 100 list of influential people in the life sciences industry. Amy was recognized for her inspirational leadership qualities and commitment to guiding the next generation of industry leaders along with her leadership in creating breakthrough strategies for sponsors. Since its inception in 2005, the PharmaVoice 100 has highlighted outstanding individuals across the industry who serve as sources of inspiration to their teams, companies and communities.
October 18, 2023
Aida Sabo receives Women in Leadership Executive Impact Award
Aida Sabo, SVP, Global DEI, was named a recipient of the 2023 Women in Leadership Executive Impact Award from Linkage. This recognition highlights Aida’s exceptional commitment to advancing women leaders at Parexel and beyond. Linkage presents the Women in Leadership Executive Impact Award annually to recognize executives who have demonstrated a deep commitment to the advancement of women leaders at their organizations, and, through their leadership, have ignited lasting and impactful change for women.
October 17, 2023
Stacy Hurt named to Fierce Pharma’s Fierce 50 list
Stacy Hurt, Patient Advocacy Ambassador, was named one of Fierce Pharma’s Fierce 50 Patient Advocacy honorees. This achievement illustrates Stacy’s unwavering commitment to amplifying the voices of patients and effecting tangible change. The Fierce 50 goes beyond surface-level accolades to delve deep into the monumental impact 50 exceptional individuals and organizations have on the lives of patients.
October 13, 2023
Parexel Receives 2023 Eagle Award
The SCRS Eagle Award recognizes the sponsor and CRO committed to outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships. The winning companies are selected based on votes cast from the global site community.
October 12, 2023
Global Investigative Sites Recognize Parexel with the 2023 Society for Clinical Research Sites Eagle Award
Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced it has been awarded the 2023 Society for Clinical Research Sites (SCRS) Eagle Award (CRO category). Parexel received the award at the annual Global Site Solutions Summit held Oct. 6-8 in Hollywood, Fla. The SCRS Eagle Award recognizes the sponsor and CRO committed to outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships.
June 15, 2023
Parexel recognized with CRO Leadership Awards
For the twelfth consecutive year, Parexel has been recognized with CRO Leadership Awards. Parexel was recognized across all five categories – Capabilities, Compatibility, Expertise, Quality, and Reliability – for exceeding customer expectations in different customer segments. Parexel’s award categories are consistent with 2022, including recognition in one new area (Expertise – Small Pharma).
June 2, 2023
Parexel receives “silver” EcoVadis rating
For the second year in a row, Parexel has received a “silver” rating in the 2023 EcoVadis Sustainability Rating Program. Each year, EcoVadis, the world’s largest and most trusted provider of business sustainability ratings, measures companies on their environmental, social and ethnical performance based on international standards across four themes (environment, ethics, labor and human rights, sustainability procurement). A silver rating is awarded to organizations with a structured and proactive sustainability approach with strong reporting on KPIs and actions. Parexel has participated in the EcoVadis Sustainability Rating Program since 2014.
May 31, 2023
Parexel rated “Top CRO to Work With” in 2023 WCG CenterWatch Survey for second straight time
Parexel has been rated the “Top CRO to Work With” by investigative sites worldwide in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey. Among the 34 CROs included in the survey, Parexel received the highest average rating across all 26 performance attributes evaluated. In addition to receiving the highest average rating across all attributes, Parexel ranked highest on four out of the five attributes considered the most important to investigative sites and was selected as the CRO that investigative sites were most willing to recommend to a colleague.
April 5, 2023
Parexel subsidiary, TMAC, recognized by Forbes as “America’s Best Recruiting and Best Temp Staffing Firm”
TMAC (The Medical Affairs Company), a subsidiary of Parexel, was named “America’s Best Recruiting and Best Temp Staffing Firm” for 2023 by Forbes. Forbes partnered with market research firm Statista to determine America’s Best Executive Recruiting Firms, consisting of 150 companies that specialize in filling positions with an annual gross income of at least $100,000.
April 1, 2023
Parexel recognized at 2023 IAC Awards for "Outstanding Online Video"
Parexel received recognition at the 2023 IAC (Internet Advertising Competition) Awards for "Outstanding Online Video" with its Doing it With Heart™ video. This international award program evaluates all forms of online advertising, including email, page-based ads, online newsletters, mobile apps, websites, video, social media and voice skills in 86 industry categories.
March 27, 2023
Parexel India recognized as a "Most Trusted Brand" by Marksmen Daily
Parexel India was recognized as one of the 2023 "Most Trusted Brands of India" by Marksmen Daily. The awards take into consideration various brand attributes, with Parexel being recognized for its advocacy, brand loyalty, brand identity, consumer perception and reciprocity. In its third year, the "Most Trusted Brands of India" awards recognize and honor brands across various industries in India that have earned consumer trust over the years.
March 24, 2023
Parexel India recognized for the fourth consecutive year at the DivHERsity Awards
Parexel has won four DivHERsity Awards, including “Top 3 Companies by Industry – Pharma/Biotech/Clinical Research,” “Top 20 Companies in DivHERsity – Large Enterprises,” “Top 20 Most Innovative Practices – DivHERsity Policies” and “Top 20 Most Innovative Practices – Women L&D Programs.” The DivHERsity Awards are a celebration of gender diversity in the workplace, recognizing companies that have shown consistent commitment to improving women's participation in the workplace.
March 22, 2023
Parexel India recognized as a "Great Place to Work® Institute (India)" certified organization
Parexel has been certified as a Great Place to Work® for the second time in three years. This certification is an honor and a testament to our culture and the commitment our Parexel India colleagues have for their work, each other and patients. Organizations are selected through a rigorous work culture assessment.
March 21, 2023
Parexel’s Amy McKee honored as a 2023 HBA Luminary
Amy McKee, M.D., Chief Medical Officer & Head of the Oncology Center of Excellence has been recognized as a 2023 Luminary by the Healthcare Businesswomen’s Association (HBA) for her service as a role model within our company, actively mentoring and sponsoring others, helping advance women’s careers and exhibiting dedication to the healthcare community.
January 9, 2023
Parexel Named a Top 100 Company to Watch for Remote Jobs in 2023
Parexel was recognized as a company to watch on FlexJobs' 10th annual list of the Top 100 Companies to Watch for Remote Jobs in 2023. Parexel is one of only five companies to have made the FlexJobs' list each year since its inception in 2014.